Substantive benefits of personalised medicine continue to elude us
For more than a decade now, we have been promised that genetic knowledge would personalise our health care. The media has told us that this information will be our own medical crystal ball, and if we fail to adhere to personalised disease prevention plans we can receive targeted medicines to treat our disease. Support for this future vision of personalised medicine has been unwavering, despite its reported slow progress.1,2
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
I am a member of the Pharmaceutical Benefits Advisory Committee and chair of the Medical Services Advisory Committee and Human Genetics Advisory Committee. The views expressed here do not represent the views of these committees.